ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions

Hepatology

Volumn 36, Issue 2, 2002, Pages 439-450

  Endo, Kanenori ^a   Yoon, Byung Il ^a   Pairojkul, Chawalit ^b   Demetris, Anthony J ^c   Sirica, Alphonse E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KHON KAEN UNIVERSITY   (Thailand)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ONCOPROTEIN; RECEPTOR PROTEIN; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER RISK; CARCINOGENESIS; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MICRODENSITOMETRY; PRIORITY JOURNAL; REGULATORY MECHANISM; TUMOR DIFFERENTIATION;

EID: 0036322129     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.34435     Document Type: Article

References (41)

1. Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies
2. NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia
3. Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma
4. Establishment of a novel rat cholangiocarcinoma cell culture model
5. Up-regulation of cyclooxygenase-2 (COX-2) in C611B rat cholangiocarcinoma cells over-expressing NEU and in neutransformed WB-F344 rat liver epithelial stem-like cells
6. Cylooxygenase-2 (COX-2) up-regulation: A common alteration in human and rat biliary cancers
7. Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma
8. c-ErbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma
9. Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan
10. Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract
11. Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma
12. Oncogene expression in cholangiocarcinoma and in normal hepatic development
13. Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver
14. c-ErbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma
15. Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma
16. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm
17. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
18. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
19. Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis
20. Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections
21. Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTest™ in breast carcinoma by image analysis
22. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma
23. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice
24. Molecular pathobiology of pancreatic adenocarcinoma
25. The genetics of pancreatic adenocarcinoma: A roadmap for a mouse model
26. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: Relevance to tumor differentiation
27. Increase expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma
28. Cyclooxygenase expression in the gallbladder
29. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma
30. Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma
31. Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohisrochemical studies of oncogene expression
32. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization
33. Genetic aberrations detected by comparative genomic hybridization in biliary tract cancers
34. Aberrant methylation of cyclooxygenase 2 CpG island in colorectal tumors
35. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells
36. Reduced COX-2 protein in colorectal cancer with defective mismatch repair
37. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability
38. Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma
39. Regulation of cyclooxygenase-2 pathway by HER2 receptor
40. Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth
41. COX-2 and ERBB-2/NEU in human and rat cholangiocarcinomas: Potential therapeutic targets [Abstract]